Honz Pharmaceutical Co., Ltd. (SHE:300086)

Honz Pharmaceutical Revenue

Honz Pharmaceutical had revenue of 48.31M CNY in the quarter ending June 30, 2026, a decrease of -59.75%. This brings the company's total for the last twelve months to 378.56M, down -21.42% year-over-year. In the year 2025, Honz Pharmaceutical had annual revenue of 466.12M, down -0.72%. That makes Honz Pharmaceutical the 26,996th largest company in the world by revenue and 4,715th in China.

• Revenue (ttm): 378.56M
• Revenue Growth: -21.42%
• P/S Ratio: 5.96
• Revenue / Employee: 701.04K
• Employees: 540
• Market Cap: 2.26B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical Manufacturing and Sales Division 431.30M 91.6%
• Daily Necessities Production and Sales Division 39.74M 8.4%

By Geography

Chart

• China 464.49M 99.7%
• Foreign 1.63M 0.3%

Fiscal year ended Dec 31, 2025 See the full Honz Pharmaceutical breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	466.12M	-3.40M	-0.72%
Jan 1, 2025	469.53M	-270.04M	-36.51%
Dec 31, 2023	739.57M	203.82M	38.05%
Jan 1, 2023	535.75M	-300.82M	-35.96%
Jan 1, 2022	836.57M	-85.08M	-9.23%

Data Source: S&P Global Market Intelligence Last updated: Aug 26, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error